CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 6. Strict requirement of caspase-9 for STP-induced radiosensitization. A, formation of active caspase-3 in E1A/ras-transformed caspase 9-deficient cells was determined after the different treatments using an antibody recognizing the cleaved caspase-3 subunit. Compare with Fig. 2 B. B, proliferation in E1A/ras-transformed caspase-9 wild-type cells ({blacksquare}) and caspase-9-deficient cells ({square}) was assessed 24 h after treatment with STP (20 nM), IR (5 Gy), or both in combination.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation